{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T13:26:37Z","timestamp":1788614797923,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T00:00:00Z","timestamp":1518480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Innovation Program of Shanghai Municipal Education Commission","award":["2017-01-07-00-07-E00057"],"award-info":[{"award-number":["2017-01-07-00-07-E00057"]}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program","doi-asserted-by":"crossref","award":["2016YFC0100604"],"award-info":[{"award-number":["2016YFC0100604"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["81671998"],"award-info":[{"award-number":["81671998"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["91542207"],"award-info":[{"award-number":["91542207"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai Science and Technology Commission","award":["16411960100"],"award-info":[{"award-number":["16411960100"]}]},{"name":"Sino-GermanTransregional Collaborative Research Centre","award":["81461130019"],"award-info":[{"award-number":["81461130019"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.antiviral.2018.02.007","type":"journal-article","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T12:53:26Z","timestamp":1518180806000},"page":"45-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Establishment of Cre-mediated HBV recombinant cccDNA (rcccDNA) cell line for cccDNA biology and antiviral screening assays"],"prefix":"10.1016","volume":"152","author":[{"given":"Min","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2018.02.007_bib1","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.drudis.2015.01.008","article-title":"Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA","volume":"20","author":"Ahmed","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.antiviral.2018.02.007_bib2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1172\/JCI58847","article-title":"IFN-alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome","volume":"122","author":"Belloni","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2018.02.007_bib3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-1-62703-484-5_13","article-title":"A southern blot assay for detection of hepatitis B virus covalently closed circular DNA from cell cultures","volume":"1030","author":"Cai","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.antiviral.2018.02.007_bib4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.antiviral.2016.05.005","article-title":"Establishment of an inducible HBV stable cell line that expresses cccDNA-dependent epitope-tagged HBeAg for screening of cccDNA modulators","volume":"132","author":"Cai","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.02.007_bib5","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/nsr\/nwv044","article-title":"New insights into hepatitis B virus biology and implications for novel antiviral strategies","volume":"2","author":"Chen","year":"2015","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.antiviral.2018.02.007_bib6","doi-asserted-by":"crossref","first-page":"35974","DOI":"10.1038\/srep35974","article-title":"MicroRNA-939 restricts Hepatitis B virus by targeting Jmjd3-mediated and C\/EBPalpha-coordinated chromatin remodeling","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2018.02.007_bib7","series-title":"Global Hepatitis Report 2017","year":"2017"},{"key":"10.1016\/j.antiviral.2018.02.007_bib8","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/mt.2010.47","article-title":"Comparative analysis of transposable element vector systems in human cells","volume":"18","author":"Grabundzija","year":"2010","journal-title":"Mol. Ther. J. Am. Soc. Gene Therapy"},{"key":"10.1016\/j.antiviral.2018.02.007_bib9","doi-asserted-by":"crossref","first-page":"15655","DOI":"10.1073\/pnas.232137699","article-title":"Infection of a human hepatoma cell line by hepatitis B virus","volume":"99","author":"Gripon","year":"2002","journal-title":"Proceed. Natnl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2018.02.007_bib10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.antiviral.2015.08.005","article-title":"Metabolism and function of hepatitis B virus cccDNA: implications for the development of cccDNA-targeting antiviral therapeutics","volume":"122","author":"Guo","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.02.007_bib11","doi-asserted-by":"crossref","first-page":"12472","DOI":"10.1128\/JVI.01123-07","article-title":"Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation","volume":"81","author":"Guo","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.02.007_bib12","article-title":"The recombined cccDNA produced using minicircle technology mimicked HBV genome in structure and function closely","volume":"6","author":"Guo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2018.02.007_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006658","article-title":"HBV core protein allosteric modulators differentially alter cccDNA biosynthesis from de novo infection and intracellular amplification pathways","volume":"13","author":"Guo","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2018.02.007_bib14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1099\/vir.0.004861-0","article-title":"Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells","volume":"90","author":"Hantz","year":"2009","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2018.02.007_bib15","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.bbrc.2013.12.052","article-title":"Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP","volume":"443","author":"Iwamoto","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2018.02.007_bib16","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/biot.201400821","article-title":"Optimized Sleeping Beauty transposons rapidly generate stable transgenic cell lines","volume":"10","author":"Kowarz","year":"2015","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.antiviral.2018.02.007_bib17","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1128\/AAC.41.8.1715","article-title":"Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication","volume":"41","author":"Ladner","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.02.007_bib18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.coviro.2016.06.003","article-title":"HBV cure: why, how, when?","volume":"18","author":"Levrero","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.antiviral.2018.02.007_bib19","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1128\/JVI.00236-10","article-title":"Inhibition of hepatitis B virus replication by MyD88 involves accelerated degradation of pregenomic RNA and nuclear retention of pre-S\/S RNAs","volume":"84","author":"Li","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.02.007_bib20","doi-asserted-by":"crossref","first-page":"36483","DOI":"10.1038\/srep36483","article-title":"Minicircle HBV cccDNA with a Gaussia luciferase reporter for investigating HBV cccDNA biology and developing cccDNA-targeting drugs","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2018.02.007_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/v9060139","article-title":"Detection of HBV covalently closed circular DNA","volume":"9","author":"Li","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2018.02.007_bib22","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.jhep.2016.02.009","article-title":"Attacking hepatitis B virus cccDNA\u2013The holy grail to hepatitis B cure","volume":"64","author":"Lucifora","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2018.02.007_bib23","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1126\/science.1243462","article-title":"Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA","volume":"343","author":"Lucifora","year":"2014","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.antiviral.2018.02.007_bib24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.antiviral.2017.07.006","article-title":"Detection of the hepatitis B virus (HBV) covalently-closed-circular DNA (cccDNA) in mice transduced with a recombinant AAV-HBV vector","volume":"145","author":"Lucifora","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.02.007_bib25","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1136\/gutjnl-2015-309809","article-title":"HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B","volume":"64","author":"Nassal","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2018.02.007_bib26","doi-asserted-by":"crossref","first-page":"8045","DOI":"10.1128\/JVI.01024-14","article-title":"Recombinant covalently closed circular hepatitis B virus DNA induces prolonged viral persistence in immunocompetent mice","volume":"88","author":"Qi","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.02.007_bib27","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.coph.2016.08.015","article-title":"Antiviral strategies to eliminate hepatitis B virus covalently closed circular DNA (cccDNA)","volume":"30","author":"Revill","year":"2016","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.antiviral.2018.02.007_bib28","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0168-8278(03)00120-X","article-title":"Primary human hepatocytes\u2013a valuable tool for investigation of apoptosis and hepatitis B virus infection","volume":"38","author":"Schulze-Bergkamen","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2018.02.007_bib29","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.virol.2015.02.031","article-title":"Molecular biology of hepatitis B virus infection","volume":"479\u2013480","author":"Seeger","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2018.02.007_bib30","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1073\/pnas.84.4.1005","article-title":"Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA","volume":"84","author":"Sells","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2018.02.007_bib31","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jhep.2016.10.009","article-title":"Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions","volume":"66","author":"Xia","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2018.02.007_bib32","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"eLife"},{"key":"10.1016\/j.antiviral.2018.02.007_bib33","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jhep.2017.02.004","article-title":"HBVcircle: a novel tool to investigate hepatitis B virus covalently closed circular DNA","volume":"66","author":"Yan","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2018.02.007_bib34","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1172\/JCI83339","article-title":"In situ analysis of intrahepatic virological events in chronic hepatitis B virus infection","volume":"126","author":"Zhang","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2018.02.007_bib35","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/hep.29133","article-title":"PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation","volume":"66","author":"Zhang","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2018.02.007_bib36","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.antiviral.2006.05.006","article-title":"Hepatitis B virus e antigen production is dependent upon covalently closed circular (ccc) DNA in HepAD38 cell cultures and may serve as a cccDNA surrogate in antiviral screening assays","volume":"72","author":"Zhou","year":"2006","journal-title":"Antivir. Res."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217305909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217305909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T20:25:39Z","timestamp":1589833539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354217305909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":36,"alternative-id":["S0166354217305909"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.02.007","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Establishment of Cre-mediated HBV recombinant cccDNA (rcccDNA) cell line for cccDNA biology and antiviral screening assays","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}